RECURRENT OR METASTATIC ENDOMETRIAL CANCER

Clinical trials for RECURRENT OR METASTATIC ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OR METASTATIC ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for RECURRENT OR METASTATIC ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New cancer drug karonudib tested for first time in humans

Disease control Completed

This early-phase trial tested a new drug, Karonudib, in 63 people with advanced solid tumors that had not responded to standard treatments. The main goal was to check the drug's safety and find the best dose. Researchers also looked at how the drug moves through the body and any …

Matched conditions: RECURRENT OR METASTATIC ENDOMETRIAL CANCER

Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control

Last updated Jun 26, 2026 15:08 UTC

RECURRENT OR METASTATIC ENDOMETRIAL CANCER

Get alerted when new RECURRENT OR METASTATIC ENDOMETRIAL CANCER trials appear

New cancer drug karonudib tested for first time in humans